Announcements
- Immutep Announces Positive Preliminary Topline Results from TACTI-003 Cohort B
- Immutep Reports Promising Clinical Data from INSIGHT-003 Trial at ESMO Congress 2023
- Immutep’s Efti in Combination with KEYTRUDA® Generates Excellent Overall Survival Benefit in Patients with Metastatic Non-Small Cell Lung Cancer
Key statistics
As of last trade Immutep Ltd (YP1A:FRA) traded at 2.52, -16.00% below its 52-week high of 3.00, set on May 22, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.52 |
---|---|
High | 2.52 |
Low | 2.52 |
Bid | 2.50 |
Offer | 2.56 |
Previous close | 2.30 |
Average volume | 1.25k |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Jun 07 2024 08:06 BST.
More ▼